Alamar Biosciences, Inc.

Contributing Author

Recent Articles by Alamar Biosciences, Inc.

Jul-28	Alamar Biosciences Launches NULISAseq Immune 340 Panel for Comprehensive Profiling of the Immune Proteome ALMR GlobeNewswire
Jul-28	Alamar Biosciences Launches NULISAseq Immune 340 Panel for Comprehensive Profiling of the Immune Proteome ALMR GlobeNewswire
Jul-14	Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 ALMR GlobeNewswire
Jul-13	Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases ALMR GlobeNewswire
Jul-10	Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling ALMR +7.33% GlobeNewswire
Jul-07	Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease Research ALMR GlobeNewswire
May-08	Alamar Biosciences Reports First Quarter 2026 Financial Results ALMR GlobeNewswire
May-05	Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference ALMR GlobeNewswire